A Phase II, Placebo Controlled, Clinical Trial of Topical TolaSure Targeting Aggregated Mutant Keratin in Epidermolysis Bullosa Simplex

Clinical trial NCT07027345 · RECRUITING

Trial details

NCT number: NCT07027345
Sponsor: BioMendics, LLC
Status: RECRUITING
Phase: Phase 2
Study type: INTERVENTIONAL

Epidermolysis Bullosa Simplex

Start date: 2025-09-11
Primary completion: 2027-01-01
Enrollment: 40

View on ClinicalTrials.gov

Track trials programmatically

Sponsors, conditions and status changes through the Atlas API.